Modulation of Costimulatory Molecules on Follicular Lymphoma Cells by TNF and CD40

References

• Liu Y. J., Banchereau J. Regulation of B‐cell commitment to plasma cells or to memory B cells. Seminars in Immunology 1997; 9: 235–240
   PubMedGoogle Scholar
• Bazzoni F., Beutler B. The Tumor Necrosis Factor Ligand and Receptor Family. New England Journal of Medicine 1996; 334: 1717–1725
   PubMed Web of Science ®Google Scholar
• Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, Ltd., New‐York, NY 1992
   Google Scholar
• Warzocha K., Bienvenu J., Coiffier B., Salles G. Mechanisms of Action of the Tumor Necrosis Factor and Lymphotoxin Ligand‐Receptor System. European Cytokine Network 1994; 5: 83–96
   Google Scholar
• Aggarwal B., Natarajan K. Tumor Necrosis Factors: Developments During the Last Decade. European Cytokine Network 1996; 7: 93–124
   PubMed Web of Science ®Google Scholar
• Pasparakis M., Alexopoulo L., Episkopoulo V., Kollias G. Immune and Inflammatory Responses in TNFα‐deficient Mice: A Critical Requirement for TNFα in the Formation of Primary B Cell Follicules, Follicular Dendritic Cell Networks and Germinal Centers, and in the Maturation of the Humoral Immune Response. Journal of Experimental Medicine 1996; 184: 1397–1411
   PubMed Web of Science ®Google Scholar
• Matsumoto M., Mariathasan S., Nahm M. H., Baranyay E., Peschon J. J., Chaplin D. D. Role of Lymphotoxin and Type I TNF Receptor in the Formation of Germinal Centers. Science 1996; 271: 1289–1291
   PubMed Web of Science ®Google Scholar
• Liu Y. ‐J., Banchereau J. Mutant Mice Without B Lymphocytes Follicles. Journal of Experimental Medicine 1996; 184: 1207–1211
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. C. K., Cleary M. L., Delsol G., de Wolf‐Peeters C., Falini B., Gat‐ter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller‐Hermelink H. ‐K., Pileri S. A., Piris M. A., Ralfkiaer E., Warlike R. A. A Revised European‐American Classification of Lymphoid Neoplasms: A proposal From the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Yang E., Korsmeyer S. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88: 386–401
   PubMed Web of Science ®Google Scholar
• Townsend S. E., Allison J. P. Tumor Rejection After Direct Costimulation of CD8+ T Cells by B7‐Trans‐fected Melanoma Cells. Science 1993; 259: 368–370
   PubMed Web of Science ®Google Scholar
• Lenschow D. J., Walunas T. L., Bluestone J. A. CD28/B7 System of T Cell Costimulation. Annual Review in Immunology 1996; 14: 233–258
   PubMed Web of Science ®Google Scholar
• Salles G., Bienvenu J., Bastion Y., Barbier Y., Doche C., Warzocha C., Gutowski M. ‐C., Rieux C., Coiffier B. Elevated Circulating Levels of TNFot and its P55 Receptor are Associated with an Adverse Prognosis in Lymphoma Patients. British Journal of Haematology 1996; 93: 352–359
   PubMed Web of Science ®Google Scholar
• Warzocha K., Salles G., Bienvenu J., Bastion Y., Dumon‐tet C., Renard N., Neidhardt E. ‐M., Coiffier B. Tumor Necrosis Factor Ligand‐Receptor System Can Predict Treatment Outcome in Lymphoma Patients. Journal of Clinical Oncology 1997; 15: 499–508
   PubMed Web of Science ®Google Scholar
• Ryffel B., Brockhaus M., Durmuller U., Gudat F. Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. American Journal of Pathology 1991; 139: 7–15
   PubMed Web of Science ®Google Scholar
• Sappino A. ‐P., Seelentag W., Pelte M. ‐F., Alberto P., Vassali P. Tumor Necrosis Factor/Cachectin and Lymphotoxin Gene Expression in Lymph Nodes Lymphoma Patients. Blood 1990; 75: 958–962
   PubMed Web of Science ®Google Scholar
• Gruss H. ‐J., Dower S. Tumor Necrosis Factor Ligand Superfamily: Involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378–3404
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Siviero F., Adami R., Marcolongo R., Raimondi R., Chisesi T., Pizzolo G., Semenzato G. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic rymphoproliferative disorders. Blood 1993; 81: 752–758
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Tumor necrosis factor‐alpha facilitates induction of CD80 (B7–1) and CD54 on human B cells by activated T cells: complex regulation by IL‐4, IL‐10, and CD40L. Cellular Immunology 1995; 161: 226–235
   PubMed Web of Science ®Google Scholar
• Garrone P., Neidhardt E. ‐M., Garcia E., Galibert L., van Kooten C., Banchereau J. Fas Ligation Induces Apoptosis of CD40‐Activated Human B lymphocytes. Journal of Experimental Medicine 1996; 182: 1265–1273
   Web of Science ®Google Scholar
• Vallé A., Garrone P., Yssel H., Bonnefoy J. ‐Y., Freedman A. S., Nadler L. M. mAb 104, a New Monoclonal Antibody, recognizes the B7 Antigen that is Expressed on Activated B Cells and HTLV‐1‐Transformed T Cells. Immunology 1990; 69: 531–535
   PubMed Web of Science ®Google Scholar
• Azuma M., Ito D., Yagita H., Okumura K., Philipps J. H., Lanier L. L., Somoza C. B70 Antigen is a Second Ligand for CTLA‐4 and CD28. Nature 1993; 366: 76–79
   PubMed Web of Science ®Google Scholar
• Stack R. M., Lenshow D. J., Gray G. S., Bluestone J. A., Fitch F. W. IL‐4 Treatment of Small Splenic B Cells Induces Costimulatory Molecules B7.1 and B7.2. Journal of Immunology 1994; 152: 5723–5733
   PubMed Web of Science ®Google Scholar
• Roy M., Aruffo A., Ledbetter J., Kerhy M., Noelle R. Studies on the Interdependence of gp39 and B7 Expression and Function During Antigen‐specific Immune Response. European Journal of Immunology 1995; 25: 596–603
   PubMed Web of Science ®Google Scholar
• Yang Y., Wilson J. M. CD40 Ligand‐Dependent T cell Activation: Requirement of B7‐CD28 Signaling through CD40. Science 1996; 273: 1862–1864
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Cantwell M. J., Kipps T. J. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 1995; 85: 3556–3565
   PubMed Web of Science ®Google Scholar
• Lens S. M., de Jong R., Hooibrink B., Koopman G., Pals S. T., van Oers M. H., van Lier R. A. Phenotype and function of human B cells expressing CD70 (CD27 ligand). European Journal of Immunology 1996; 26: 2964–2971
   PubMed Web of Science ®Google Scholar
• Adami R., Guarini A., Pini M., Siviero R., Sancetta R., Massiai M., Trentin L., Foa R., Semenzato G. Serum levels of tumor necrosis factor‐alpha in patients with B‐cell chronic lymphocytic leukaemia. European Journal of Cancer 1994; 30A: 1259–1263
   PubMed Web of Science ®Google Scholar
• Macia J., Gomez X., Perez B. Prognostic Value of Tumor Necrosis Factor in Plasma of Patients with Chronic Lymphocytic Leukemia. Blood 1994; 84: 989–991
   PubMed Web of Science ®Google Scholar
• Schultze J. L., Cardoso A. A., Freeman G. R., Seamon M. J., Daley J., Pinkus G. S., Gribben J. G., Nadler L. M. Follicular Lymphomas Can be Induced to Present Alloantigen Efficiently: A Conceptual Model to Improve Their Tumor Immunogenicity. Proceedings of the National Academy of Sciences (USA) 1995; 92: 8200–8204
   PubMed Web of Science ®Google Scholar
• Plumas J., Chaperot L., Jacob M. ‐C., Molens J. P., Giroux C., Sotto J. ‐J., Bensa J. ‐C. Malignant B Lymphocytes From Non‐Hodgkin's Lymphoma Induce Allogeneic Proliferative and Cytotoxic T Cell Responses in Primary Mixed Lymphocyte Cultures: an Important Role of Costimulatory Molecules CD80 (B7.1)and CD86 (B7.2) in Stimulation by Tumor Cells. European Journal of Immunology 1995; 25: 3332–3341
   PubMed Web of Science ®Google Scholar
• Shamash J., Davies D. C., Salam A., Rohatiner A. Z., Young B. D., Lister T. A. Induction of CD80 expression in low‐grade B cell lymphoma—a potential immunotherapeutic target. Leukemia 1995; 9: 1349–1352
   PubMed Web of Science ®Google Scholar
• Jeanin P., Delneste Y., Lecoanet‐Henchoz S., Gauchat J. ‐R., Ellis J., Bonnefoy J. ‐Y. CD86 (B7.2) on Human B cells. Journal of Biological Chemistry 1997; 272: 15613–15619
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40‐dependent signal. Journal of Experimental Medicine 1993; 177: 925–935
   PubMed Web of Science ®Google Scholar
• Vallé A., Aubry J. ‐P., Durand I., Bancherau J. IL‐4 and IL‐2 Upregulate the Expression of the Antigen B7, the B Cell counterstructure to T Cell CD28: an Amplification Mechanism for T‐B cell Interactions. International Immunology 1991; 3: 229–235
   PubMed Web of Science ®Google Scholar
• Lahvis G. P., Cerny J. Induction of Germinal Center B Cell Markers In Vitro by activated CD4+ T Lymphocytes. The Role of CD40 Ligand, Soluble Factors, and B Ceil Antigen Receptor Cross‐Linking. Journal of Immunology 1997; 159: 1783–1793
   PubMed Web of Science ®Google Scholar
• van Oers M. H., Pals S. T., Evers L. M., van der Schoot C. E., Koopman G., Bonfrer J. M., Hintzen R. Q., von dem Borne A. E., van Lier R. A. Expression and release of CD27 in human B‐cell malignancies. Blood 1993; 82: 3430–3436
   PubMed Web of Science ®Google Scholar
• Lens S. M., de Jong R., Hintzen R. Q., Koopman G., van Lier R. A., van Oers R. H. CD27‐CD70 interaction: unraveling its implication in normal and neoplastic B‐cell growth. Leukemia and Lymphoma 1995; 18: 51–59
   PubMed Web of Science ®Google Scholar
• Maurer D., Holter W., Majdic O., Fischer G. F., Knapp W. CD27 Expression by a Distinct Subpopulation of Human B Lymphocytes. European Journal of Immunology 1990; 20: 2679–2684
   PubMed Web of Science ®Google Scholar
• Lens S. M., Keehnen R. M., van Oers M. H., van Lier R. A., Pals S. T., Koopman G. Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. European Journal of Immunology 1996; 26: 1007–1011
   PubMed Web of Science ®Google Scholar
• Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fuku‐shima K., Yasui K., Ito S., Kobata T., Morimoto C., Komiyama A. Generation of Plasma Cells From Peripheral Blood Memory B Cells: Synergistic Effect of Interleukin‐10 and CD27/CD70 Interaction. Blood 1998; 91: 173–180
   PubMed Web of Science ®Google Scholar
• Digel W., Stefanic M., Schoniger W., Buck C., Raghava‐char A., Frickhofen N., Heimpel H., Porzsolt F. Tumor necrosis factor induces proliferation of neoplastic B‐Cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–1246
   PubMed Web of Science ®Google Scholar
• Brown G. R., Meek K., Nishioka Y., Thiele D. L. CD27‐CD27 ligand/CD70 interactions enhance alloantigen‐induced proliferation and cytolytic activity in CD8+ T lymphocytes. Journal of Immunology 1995; 154: 3686–3695
   PubMed Web of Science ®Google Scholar
• Ramarathinam L., Castle M., Wu Y., Liu Y. T cell Costimulation by B7/BB1 Induces CD8 T Cell‐dependent Tumor Rejection: An Important.Role of B7/BB in the Induction, Recruitment, and Effector Function of Antitumor T Cells. Journal of Experimental Medicine 1994; 179: 1205–1214
   PubMed Web of Science ®Google Scholar
• Chen L., Ashe S., Brady W., Hellström I., Hellström K. E., Ledbetter J. A., McGowan P., Linsley P. S. Costimulation of Antitumor Immunity by the B7 Counter‐receptor for the T Lymphocyte Molecules CD28 and CTLA‐4. Cell 1992; 71: 1093–1102
   PubMed Web of Science ®Google Scholar
• Chen L., McGowan P., Ashe S., Johnston J., Li Y., Hellström I., Hellström K. E. Tumor Immunogenicity Determines the Effect of B7 Costimulation on T Cell‐mediated Tumor Immunity. Journal of Experimental Medicine 1994; 179: 523–532
   PubMed Web of Science ®Google Scholar
• Viola A., Lanzavecchia A. T Cell Activation Determined by T cell Receptor Number and Tunable Thresholds. Science 1996; 273: 104–106
   PubMed Web of Science ®Google Scholar